Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BIPOLAR I DISORDER”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06929273
What this trial is testing

Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

Who this might be right for
Bipolar Disorder Type I With Mania
Bristol-Myers Squibb 450
Not applicableActive Not RecruitingNCT03484494
What this trial is testing

Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression

Who this might be right for
Bipolar DisorderBipolar DepressionBipolar I Disorder+1 more
Mclean Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00709202
What this trial is testing

Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+5 more
Nathan Kline Institute for Psychiatric Research 48
Not applicableStudy completedNCT00006517
What this trial is testing

Clinical Trials of Three Non-Drug Treatments for Winter Depression (SAD)

Who this might be right for
Seasonal Affective DisorderMood DisordersDepression
New York State Psychiatric Institute 150
Large-scale testing (Phase 3)Looking for participantsNCT07140913
What this trial is testing

Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine

Who this might be right for
ManiaBipolar Disorder
Bristol-Myers Squibb 424
Testing effectiveness (Phase 2)Study completedNCT03692910
What this trial is testing

Evaluate SAGE-217 in Participants With Bipolar I/II Disorder With a Current Major Depressive Episode

Who this might be right for
Bipolar Disorder IBipolar Disorder IIMajor Depressive Episode
Biogen 35
Not applicableEnrolling By InvitationNCT07239843
What this trial is testing

Prospective Observational Study of the Relationship Between Sociodemographic Factors, Blood-based Biomarkers and Psychiatric Symptoms in Neurodegenerative Diseases and Mental Disorders

Who this might be right for
Major Depressive Disorder (MDD)Schizophenia DisorderBipolar 1 Disorder+4 more
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 1,310
Not applicableStudy completedNCT02330068
What this trial is testing

Microbiome of Depression & Treatment Response to Citalopram

Who this might be right for
Major Depressive Disorder, Bipolar I and Bipolar II
Mayo Clinic 34
Early research (Phase 1)Study completedNCT01206517
What this trial is testing

Evaluate the Pharmacokinetics, Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder (P06522 AM1)

Who this might be right for
SchizophreniaBipolar I Disorder
Organon and Co 30
Early research (Phase 1)Study completedNCT00892125
What this trial is testing

The Effect of Carbamazepine on the Pharmacokinetics of Paliperidone Extended Release (ER) in Patients With Schizophrenia or Bipolar I Disorder

Who this might be right for
SchizophreniaBipolar Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 64
Testing effectiveness (Phase 2)Study completedNCT03543410
What this trial is testing

A Clinical Study to Test the Effectiveness of an Investigational Drug to Treat People That Have Major Depressive Episodes When They Have Bipolar 1 Depression

Who this might be right for
Depressive EpisodeBipolar 1 Depression
Sumitomo Pharma America, Inc. 344
Not applicableStudy completedNCT05878808
What this trial is testing

Obsessions and Suicidality in Youth With Bipolar 1 Disorder

Who this might be right for
ObsessionsSuicideBipolar I Disorder+1 more
Cairo University 80
Large-scale testing (Phase 3)Study completedNCT01058668
What this trial is testing

Safety and Efficacy of Cariprazine for Bipolar I Disorder

Who this might be right for
ManiaBipolar I Disorder
Forest Laboratories 497
Post-approval studies (Phase 4)Study completedNCT00181844
What this trial is testing

Lamotrigine for the Treatment of Mania in Youth Ages 6-17 With Bipolar Disorder

Who this might be right for
Bipolar DisorderMania
Massachusetts General Hospital 51
Large-scale testing (Phase 3)Study completedNCT00046384
What this trial is testing

Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder

Who this might be right for
Bipolar I Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc.
Not applicableLooking for participantsNCT06134349
What this trial is testing

The Bipolar Lithium Imaging Scan Study.

Who this might be right for
Bipolar Disorder I or II
Leiden University Medical Center 80
Large-scale testing (Phase 3)WithdrawnNCT01685151
What this trial is testing

A Safety and Efficacy Study of Ramelteon Tablets for Sublingual Administration (TAK-375SL) in the Maintenance Treatment of Bipolar 1 Disorder

Who this might be right for
Bipolar Disorder
Takeda
Large-scale testing (Phase 3)WithdrawnNCT00338273
What this trial is testing

Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode

Who this might be right for
Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT07288320
What this trial is testing

An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania

Who this might be right for
Bipolar I DisorderMania
Neurocrine Biosciences 150
Post-approval studies (Phase 4)Study completedNCT00154323
What this trial is testing

The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Bipolar Disorder I or II This Study is Not Being Conducted in the United States.

Who this might be right for
Bipolar Disorder
Novartis 55
Next Page